20014 ⎘
Medicinal preparations characterised by special physical form; Galenical forms characterised by the drug release technique; Application systems commanded by energy Osmotic delivery systems; Sustained release driven by osmosis, thermal energy or gas
BIOERODIBLE OCULAR DRUG DELIVERY INSERT AND THERAPEUTIC METHOD
#2Two-Stage Microchip Drug Delivery Device and Methods
#3Multi-Unit Drug Delivery Devices and Methods
#4EXTENDED RELEASE UPADACITINIB FORMULATIONS
#5COIL ELECTRODE HAVING TUBULAR INSULATION
#61-(NAPHTHALEN-2-YL)-3-AZABICYCLO[3.1.0]HEXANE FOR TREATING MAJOR DEPRESSIVE DISORDER
#7WEARABLE DEVICE HAVING PISTON DISPLACEMENT MONITORING
#8ENVIRONMENTALLY BIODEGRADABLE COMPOSITIONS COMPRISING AN AMINO ACID ADDUCT, CONTROLLED RELEASE PARTICLES AND COMPOSITIONS COMPRISING SAME, AND METHODS OF MAKING SAME
#9METHODS FOR THE PREVENTION OR TREATMENT OF LEFT VENTRICLE REMODELING
#10STING AGONIST-CONTAINING UREASE-POWERED NANOMOTOR-BASED BLADDER CANCER IMMUNOTHERAPY AGENT
#11METHODS FOR TREATING SUBJECTS WITH PRADER-WILLI SYNDROME
#12OSMOTIC PUMP TABLET, PREPARATION METHOD THEREFOR AND USE THEREOF
#13METHODS FOR PREVENTING OR SLOWING THE PROGRESSION OF COGNITIVE DECLINE OR IMPAIRMENT IN SUBJECTS DISPLAYING NORMAL COGNITIVE PERFORMANCE
#14BOOSTING OSMOTIC BLOOD-ORGAN BARRIER OPENING FOR IMPROVED DELIVERY OF THERAPEUTICS TO ORGANS
#15OSMOTIC TABLETS OF DEXPRAMIPEXOLE AND METHODS OF MANUFACTURING AND USE THEREOF
#16DRUG INJECTION DEVICE AND METHOD
#17DRUG INJECTION DEVICE AND METHOD
#18NITROGENOUS GAS SUSTAINED RELEASING AGENT AND NITROGENOUS GAS SUSTAINED RELEASER COMPOSED OF THE SAME AS WELL AS NITROGENOUS GAS SUSTAINED RELEASING METHOD, RESPIRATORY EQUIPMENT, PACKAGE, AND SUSTAINED RELEASING APPARATUS USING THE SUSTAINED RELEASER
#19EXTENDED RELEASE UPADACITINIB FORMULATIONS
#20FORMULATIONS OF MAZINDOL
#21COMPOSITIONS COMPRISING ULTRAFINE BUBBLES AND METHODS OF USING THEREOF IN BEVERAGES, FOOD PRODUCTS, SKIN AND HAIR CARE PRODUCTS, ORAL CARE PRODUCTS, FLAVOR AND SENSATION ENHANCERS, AND TOPICALLY APPLIED PRODUCTS
#22OSMOTIC PUMP CONTROLLED-RELEASE TABLET OF INSOLUBLE DRUG AND PREPARATION METHOD THEREFOR
#23ORAL PHARMACEUTICAL COMPOSITION
#24CONTROLLED DRUG RELEASE PREPARATION COMPOSITION AND CONTROLLED DRUG RELEASE PREPARATION
#25METHODS FOR TREATING SUBJECTS WITH PRADER-WILLI SYNDROME OR SMITH-MAGENIS SYNDROME
#26Method and Apparatus for Drug Delivery to Surgical Margins
#27ADJUSTABLE RATE DRUG DELIVERY IMPLANTABLE DEVICE
#28ORAL PHARMACEUTICAL COMPOSITION CONTAINING HETEROCYCLIC COMPOUND
#29METHOD OF PRODUCING AN ORAL OSMOTIC PHARMACEUTICAL DELIVERY SYSTEM AND A PHARMACEUTICAL BATCH PRODUCED USING THE SAME
#30LONG ACTING GLUCAGON LIKE POLYPEPTIDE-1 (GLP-1) RECEPTOR AGONISTS AND METHODS OF USE
#31OSMOTIC AGENT COMPOSITION COMPRISING ACIDSENSITIVE INGREDIENT
#32Drug Delivery Devices and Methods for Drug Delivery
#33Methods for treating subjects with Prader-Willi syndrome or Smith-Magenis syndrome
#34Biodegradable Implant for Sustained Trans-Nasal Delivery of Therapeutic Agents to the Brain
#35HUMAN AMYLIN ANALOG POLYPEPTIDES AND METHODS OF USE
#36EXTENDED RELEASE UPADACITINIB FORMULATIONS
#37OSMOTIC DOSAGE FORMS COMPRISING DEUTETRABENAZINE AND METHODS OF USE THEREOF
#38Compositions Comprising Antioxidant, Fluid Dispensers, and Methods Involving the Same
#39TREATMENT OF A DISEASE OF THE GASTROINTESTINAL TRACT WITH A JAK INHIBITOR AND DEVICES
#40GLUCAGON-RECEPTOR SELECTIVE POLYPEPTIDES AND METHODS OF USE THEREOF
#41DEVICES FOR IN SITU FORMED NERVE CAPS AND/OR NERVE WRAPS
#42METHODS OF OTOPROTECTION AGAINST PLATINUM-BASED ANTINEOPLASTIC AGENTS
#43Methods for treating subjects with Prader-Willi syndrome or Smith-Magenis syndrome
#44DRUG DELIVERY IMPLANTS WITH BI-DIRECTIONAL DELIVERY CAPACITY AND METHODS OF USING SAME
#45CONTROLLED FLOW DRUG DELIVERY IMPLANTABLE DEVICE
#46OSMOTIC ENERGY TRANSFER DEVICES AND METHODS
#47METHODS OF OTOPROTECTION AGAINST PLATINUM-BASED ANTINEOPLASTIC AGENTS
#48Clinical Dosing Schedule of Inositol Phosphate Oligo(Ethylene Glycol) Compounds
#49Solid Drug Tablets for Implantable Drug Delivery Devices
#50BIOADHESIVE FILM AND METHODS OF USE THEREOF
#51CONTINUOUS ADMINISTRATION DEVICE
#52SELF-REGULATING OSMOTIC GASTRORETENTIVE DRUG DELIVERY SYSTEMS
#53Monolithic Implantable Device for Sustained Release of an Antibody
#54METHOD AND SYSTEM FOR DRUG DELIVERY
#55TREATMENT OF AUTISM SPECTRUM DISORDER AND ASSOCIATED SYMPTOMS
#56ABCD1 FOR TREATMENT OF NEURODISORDERS
#57Sustained Release Compositions Comprising Liothyronine
#58TREATMENT OF A DISEASE OF THE GASTROINTESTINAL TRACT WITH A TNF INHIBITOR
#59SALT RESPONSIVE NANOGELS AND NANOPARTICLES
#60Artificial Cells and Delivery Devices for Use in Tissue Engineering, and Related Methods
#61LUMEN INSERTABLE CAPSULE
#62OSMOTIC DRUG DELIVERY SYSTEM
#63METHODS AND SYSTEMS FOR ASSEMBLING INTRAVESICAL DRUG DELIVERY DEVICES
#64OSMOTIC DRUG DELIVERY IMPLANTS
#65FORMULATIONS OF MAZINDOL
#66Controlled flow drug delivery implantable device
#67PHARMACEUTICAL SUSPENSIONS CONTAINING DRUG PARTICLES, DEVICES FOR THEIR ADMINISTRATION, AND METHODS OF THEIR USE
#68LIPOLYSIS COMPOSITION USING SURFACE-MODIFIED GAS-GENERATING NANOPARTICLES
#69MACROCYCLIC LACTONE COMPOUNDS AND METHODS FOR THEIR USE
#70OSMOTIC MEDIATED RELEASE SYNTHETIC NANOCARRIERS
#71IMPLANTABLE MATRIX FOR TREATING CENTRAL NERVOUS SYSTEM DISORDERS
#72Methods of treating tumor metastasis
#73Heat Substrate and/or Image Enhancement Compositions and Enhanced Tissue Ablation Methods
#74Long acting glucagon like polypeptide-1 (GLP-1) receptor agonists and methods of use
#75SOLID PREPARATION, AND PREPARATION METHOD THEREFOR AND USE THEREOF
#76OSMOTIC DOSAGE FORMS COMPRISING DEUTETRABENAZINE AND METHODS OF USE THEREOF
#77MODIFIED RELEASE PHARMACEUTICAL COMPOSITIONS OF RIOCIGUAT
#78NICOTINE SALT WITH META-SALICYLIC ACID AND APPLICATIONS THEREIN
#79COMPOSITION CONTAINING LEGOAMODIPINE BESYLATE HYDRATE AND PREPARATION METHOD THEREFOR
#80COMPOSITION AND METHOD FOR TREATMENT OF DIABETES
#811-(((2S,3S,4S)-3-ETHYL-4-FLUORO-5-OXOPYRROLIDIN-2-YL)METHOXY)-7-METHOXYISOQUINOLINE-6-CARBOXAMIDE COMBINATIONS AND ORAL DOSAGE FORMS
#82ADJUSTABLE RATE DRUG DELIVERY IMPLANTABLE DEVICE
#83PROGRAMMABLE PHARMACEUTICAL COMPOSITIONS FOR CHRONO DRUG RELEASE
#84SYNERGISTIC THERAPIES FOR INTERVERTEBRAL DISC DEGENERATION
#85METHODS FOR TREATMENT OF BLADDER CANCER WITH GEMCITABINE
#86PROGRAMMABLE PHARMACEUTICAL COMPOSITIONS FOR CHRONO DRUG RELEASE
#87METHODS FOR DELIVERING ETANERCEPT PREPARATIONS INTO A LUMEN OF THE INTESTINAL TRACT USING A SWALLOWABLE DRUG DELIVERY DEVICE
#88Glucagon-receptor selective polypeptides and methods of use thereof
#89METHODS FOR THE PREVENTION OR TREATMENT OF LEFT VENTRICLE REMODELING
#90OSMOTIC DOSAGE FORMS COMPRISING DEUTETRABENAZINE AND METHODS OF USE THEREOF
#91ORAL PHARMACEUTICAL COMPOSITION
#92ORALLY ADMINISTRABLE MODIFIED-RELEASE PHARMACEUTICAL DOSAGE FORM
#93CONTROLLED RELEASE FORMULATION DELIVERY DEVICE
#94ATOMOXETINE HYDROCHLORIDE EXTENDED RELEASE COMPOSITIONS AND METHODS OF USE
#95GASTRORETENTIVE DOSAGE FORMS OF LEVODOPA AND CARBIDOPA
#96Fast dissolving pharmaceutical compositions
#97Nitrogenous gas sustained releasing agent and nitrogenous gas sustained releaser composed of the same as well as nitrogenous gas sustained releasing method, respiratory equipment, package, and sustained releasing apparatus using the sustained releaser
#98COMPOSITION AND METHOD FOR TREATING NEUROLOGICAL DISEASE
#99Microcapsule With A Porous Or Hollow Core And A Shell Containing A Component Releasing Gas Upon Contact With An Acid
#100Sustained release compositions comprising liothyronine
#101Implants for localized drug delivery and methods of use thereof
#102BIOERODIBLE OCULAR DRUG DELIVERY INSERT AND THERAPEUTIC METHOD
#103Drug Adsorbed Highly Porous Activated Carbon for Enhanced Drug Delivery
#104METHODS FOR TREATMENT OF BLADDER CANCER WITH GEMCITABINE
#105Treatment of a disease of the gastrointestinal tract with a JAK inhibitor and devices
#106Fluid storage media and method of delivering a fluid
#107DRUG DELIVERY SYSTEM AND METHOD FOR CONTROLLED AND CONTINUOUS DELIVERY OF DRUGS INTO THE BRAIN BY BYPASSING THE BLOOD BRAIN BARRIER.
#108METHOD OF FACILITATING NERVE GROWTH
#109Programmable pharmaceutical compositions for chrono drug release
#110Antidiabetic pharmaceutical compositions and preparation method thereof
#111DELAYED RELEASE COMPOSITIONS
#112DEVICE FOR ORAL DELIVERY OF ACTIVE AGENTS
#113SHORT-ACTING SELECTIVE GLUCOCORTICOID RECEPTOR MODULATORS
#114Devices for in situ formed nerve caps and/or nerve wraps
#115Multi-lumen drug delivery devices and methods
#116Self-regulating osmotic gastroretentive drug delivery systems
#117Coated hollow and evacuated insulation spheres (CEIS)
#118PEROXIDE REMOVAL FROM DRUG DELIVERY VEHICLE
#119Devices for the administration of pharmaceutical suspensions
#120Controlled release dosage form
#121Intravesical device for controlled drug delivery
#122Programmable pharmaceutical compositions for chrono drug release
#123OTIC GEL FORMULATIONS FOR TREATING OTITIS EXTERNA
#124Osmotic dosage forms comprising deutetrabenazine and methods of use thereof
#125Biodegradable implant for sustained trans-nasal delivery of therapeutic agents to the brain
#126Composition and method for treating neurological disease
#127Composition and method for treating neurological disease
#128Reduction of Pulmonary Inflammation Using Therapeutic Gas Mixtures
#129Insulins Compatible with New Generation Implantable Pumps
#130Compositions Comprising Antioxidant, Fluid Dispensers, and Methods Involving the Same
#131METHODS FOR TREATING SUBJECTS WITH PRADER-WILLI SYNDROME OR SMITH-MAGENIS SYNDROME
#132STABILIZED FORMULATIONS OF CNS COMPOUNDS
#133Solid drug tablets for implantable drug delivery devices
#134Controlled release dosage form with enhanced pharmacokinetics
#135PHARMACEUTICAL DOSAGE FORM WHICH CAN BE ADMINISTERED ORALLY AND HAS MODIFIED RELEASE
#136Drug delivery devices and methods for drug delivery
#137DEVICES AND METHODS FOR CONTINUOUS DRUG DELIVERY VIA THE MOUTH
#138AN OSMOTIC ACTUATOR FOR AN INJECTING DEVICE AND AN INJECTION DEVICE COMPRISING SUCH AN OSMOTIC ACTUATOR
#139DEVICE FOR ORAL DELIVERY OF ACTIVE AGENTS
#140Method and system for drug delivery
#141Rapid establishment and/or termination of substantial steady-state drug delivery
#142STRUCTURE
#143Programmable pharmaceutical compositions for chrono drug release
#144Programmable pharmaceutical compositions for chrono drug release
#145Methods and devices for in situ formed nerve cap
#146COMPOSITIONS FOR THE TREATMENT AND PREVENTION OF EYELID SWELLING
#147Controlled-release system of active pharmaceutical ingredient and preparation method therefor
#148Delivery Capsule with Threshold Release
#149Methods of treating tumor metastasis
#150MODIFIED-RELEASE TIOPRONIN COMPOSITIONS, KITS AND METHODS FOR TREATING CYSTINURIA AND RELATED DISORDERS
#151Self-regulating osmotic gastroretentive drug delivery systems
#152Two Stage Microchip Drug Delivery Device and Methods
#153Orally administrable modified-release pharmaceutical dosage form
#154Pharmaceutical composition for modified release
#155Self-regulating osmotic gastroretentive drug delivery systems
#156Process for Producing Water and Other Fluids with Increased Levels of a Measurable Life Force Energy by Placing the Fluids in the Proximity of Containers of Water with Existing High Levels of the Life Force Energy
#157Methods of otoprotection against platinum-based antineoplastic agents
#158Programmable pharmaceutical compositions for chrono drug release
#159Pharmaceutical composition and preparation method therefor and use thereof
#160Controlled release of radionuclides
#161MACROCYCLIC LACTONE COMPOUNDS AND METHODS FOR THEIR USE
#162Devices for the administration of pharmaceutical suspensions
#163Programmable pharmaceutical compositions for chrono drug release
#164Solid drug tablets for implantable drug delivery devices
#165THERAPEUTIC METHODS FOR THE TREATMENT OF DIABETES AND RELATED CONDITIONS FOR PATIENTS WITH HIGH BASELINE HbA1c
#166DEVICE FOR ORAL DELIVERY OF ACTIVE AGENTS
#167MULTI-UNIT DRUG DELIVERY DEVICES AND METHODS
#168THERAPEUTIC METHODS FOR THE TREATMENT OF DIABETES AND RELATED CONDITIONS FOR PATIENTS WITH HIGH BASELINE HbA1c
#169MULTI-UNIT DRUG DELIVERY DEVICES AND METHODS
#170METHODS AND COMPOSITIONS UTILIZING RRx-001 FOR RADIOPROTECTION
#171Self-regulating osmotic gastroretentive drug delivery systems
#172Methods for delivering etanercept preparations into a lumen of the intestinal tract using a swallowable drug delivery device
#173OSMOTIC PUMP CONTROLLED RELEASE FORMULATIONS
#174Glucagon-receptor selective polypeptides and methods of use thereof
#175Implantable ocular drug delivery devices and methods
#176Treatment of autism spectrum disorder and associated symptoms
#177METHOD FOR PREPARING A SOLID DOSAGE FORM COMPRISING ANTIBODIES BY WET GRANULATION, EXTRUSION AND SPHERONIZATION
#178OSMOTIC DRUG DELIVERY SYSTEM
#179Programmable pharmaceutical compositions for chrono drug release
#180PHARMACEUTICAL FORMULATIONS OF POTASSIUM ATP CHANNEL OPENERS AND USES THEREOF
#181Method of administering amantadine prior to a sleep period
#182ORALLY ADMINISTRABLE MODIFIED-RELEASED PHARMACEUTICAL DOSAGE FORM
#183Self-Assembled Microcapsules for Optically Controlled Cargo Encapsulation and Release
#184Pharmaceutical suspensions containing drug particles, devices for their administration, and methods of their use
#185Tofacitinib oral sustained release dosage forms
#186Treatment of a disease of the gastrointestinal tract with a JAK inhibitor and devices
#187APPARATUS AND METHODS FOR ADMINISTRATION OF A NAUSEOGENIC COMPOUND FROM A DRUG DELIVERY DEVICE
#188Controlled release dosage form
#189Self-regulating osmotic gastroretentive drug delivery systems
#190EXTENDED RELEASE CONJUGATES OF EXENATIDE ANALOGS
#191Self-regulating osmotic gastroretentive drug delivery systems
#192Methods for treating subjects with Prader-Willi syndrome or Smith-Magenis syndrome
#193COMPOSITION AND METHOD FOR TREATING NEUROLOGICAL DISEASE
#194COMPOSITION AND METHOD FOR TREATING NEUROLOGICAL DISEASE
#195Controlled release dosage form with enhanced pharmacokinetics
#196Human amylin analog polypeptides and methods of use
#197Intravesical drug delivery device with retention frame and drug tablets
#198REACTIONS TRIGGERED BY COOLING-INDUCED GEL-TO-SOL TRANSITION OF THERMORESPONSIVE POLYMERS
#199Oral medicament comprising an osmotic laxative incorporated into a matrix based on plant fats with reduced doses of macrogol
#200PHARMACEUTICAL COMPOSITIONS WITH SYNCHRONIZED SOLUBILIZER RELEASE
#201METHODS AND COMPOSITIONS FOR TREATING DISORDERS ASSOCIATED WITH MUSCLE WEAKNESS
#202Suspension formulation comprising an insulinotropic peptide
#203THERAPEUTIC AGENT FOR SHORT STATURE
#204Orally administrable modified-release pharmaceutical dosage form
#205MARIJUANA BEVERAGE SPIKER AND METHOD
#206Systems Methods Devices Apparatuses Circuits and Computer Executable Code for Production and Topical Application of a Therapeutic Substance
#207Oral Therapeutic Compound Delivery System
#208Peroxide removal from drug delivery vehicle
#209Pharmaceutical suspensions containing drug particles, devices for their administration, and methods of their use
#210METHODS FOR THE PREVENTION OR TREATMENT OF LEFT VENTRICLE REMODELING
#211Treatment of autism spectrum disorder and associated symptoms
#212Adjustable rate drug delivery implantable device
#213OSMOTIC DRUG DELIVERY SYSTEM
#214Artificial cells and delivery devices for use in tissue engineering, and related methods
#215Drug Condensation Aerosols And Kits
#216Thermosensitive nanocapsules and preparing method thereof
#217COMPOSITION AND METHOD FOR TREATING NEUROLOGICAL DISEASE
#218Methods for delivering etanercept preparations into a lumen of the intestinal tract using a swallowable drug delivery device
#219Macrocyclic lactone compounds and methods for their use
#220Salt responsive nanogels and nanoparticles
#221Controlled release dosage form
#222COMPOSITION AND METHOD FOR TREATING NEUROLOGICAL DISEASE
#223Composition and method for treating neurological disease
#224Composition and method for treating neurological disease
#225Composition and method for treating neurological disease
#226Composition and method for treating neurological disease
#227Sustained Release Pharmaceutical Dosage Form of Entecavir
#228Compositions Comprising Antioxidant, Fluid Dispensers, and Methods Involving the Same
#229Intrathecal delivery of nucleic acid sequences encoding ABCD1 for treatment of adrenomyeloneuropathy
#230DELAYED-RELEASE FORMULATIONS, METHODS OF MAKING AND USE THEREOF
#231Osmotic energy transfer devices and methods
#232Nicotine salt with meta-salicylic acid and applications therein
#233In vivo drug delivery devices and methods for drug delivery
#234INJECTABLE SUSTAINED RELEASE DELIVERY DEVICES
#235Implants for localized drug delivery and methods of use thereof
#236Dose-dumping resistant controlled release dosage form
#237Controlled release dosage form
#238Pharmaceutical suspensions containing drug particles, devices for their administration, and methods of their use
#239Controlled release dosage form
#240Methods for treating subjects with Prader-Willi syndrome or Smith-Magenis syndrome
#241Methods and compositions for treating aging-associated impairments using CCR3-inhibitors
#242Rapid establishment and/or termination of substantial steady-state drug delivery
#243METHOD FOR DRY POWDER COATING OSMOTIC DRUG DELIVERY SYSTEM
#244Controlled Release Dosage Form for Once Daily Administration of Dimethyl Fumarate
#245Multi-lumen drug delivery devices
#246Metformin hydrochloride osmotic pump tablet and preparation method therefor
#247Controlled release dosage form with enhanced pharmacokinetics
#248Methods of treating tumor metastasis
#249Stabilized formulations of CNS compounds
#250Implantable drug delivery device
#251Controlled Release Dosage Form for Once Daily Administration of Dimethyl Fumarate
#252EXTENDED RELEASE OSMOTIC DOSAGE FORM COMPRISING HIGH METHYLPHENIDATE HYDROCHLORIDE LOAD
#253CONTROLLED RELEASE HYDROCODONE FORMULATIONS
#254Device for delivery of smokable cannabis and manufacturing method for same
#255SINGLE CHANNEL, MULTIPLE DRUG DELIVERY DEVICE AND METHODS
#256Drug delivery device
#257INTRATHECAL DELIVERY OF NUCLEIC ACID SEQUENCES ENCODING ABCD1 FOR TREATMENT OF ADRENOMYELONEUROPATHY
#258Methods and devices for renal nerve blocking
#259Drug delivery implants with bi-directional delivery capacity
#260PHARMACEUTICAL FORMULATIONS OF POTASSIUM ATP CHANNEL OPENERS AND USES THEREOF
#261AMANTADINE COMPOSITIONS AND METHODS OF USE
#262Treatment of pediatric brain tumors with targeting of CD47 pathway
#263Devices, formulations, and methods for delivery of multiple beneficial agents
#264Therapeutic methods for the treatment of diabetes and related conditions for patients with high baseline HbA1c
#265Retentive devices and systems for in-situ release of pharmaceutical active agents
#266Dose-dumping resistant controlled release dosage form
#267Controlled release dosage form
#268Controlled release dosage form
#269DEVICE FOR ORAL DELIVERY OF ACTIVE AGENTS
#270COMPOSITIONS AND METHODS FOR INJECTION OF A BIODEGRADABLE POLYMER-BASED DELIVERY SYSTEM
#271Tofacitinib oral sustained release dosage forms
#272MICROFABRICATED NANOPORE DEVICE FOR SUSTAINED RELEASE OF THERAPEUTIC AGENT
#273Methods for delivering entanercept preparations into a lumen of the intestinal tract using a swallowable drug delivery device
#274Formulations to achieve rapid dissolution of drug from spray-dried dispersions in capsules
#275Drug coating layer
#276Heat substrate and/or image enhancement compositions and enhanced tissue ablation methods
#277PHARMACEUTICAL COMPOSITIONS WITH SYNCHRONIZED SOLUBILIZER RELEASE
#278Otic gel formulations for treating otitis externa
#279Intravesical device for controlled drug delivery
#280Drug delivery devices and methods for drug delivery
#281Adjustable rate drug delivery implantable device
#282Methods for treating subjects with prader-willi syndrome or smith-magenis syndrome
#283Nicotine salt with meta-salicylic acid and applications therein
#284Glucagon-receptor selective polypeptides and methods of use thereof
#285EXTENDED RELEASE COMPOSITIONS OF AN AMINOALKYL NITRATE
#286METHOD FOR PREVENTING, TREATING, AND CURING CANCER
#287Method of manufacturing an osmotic delivery device
#288Method and system for drug delivery
#289Controlled release dosage form
#290TREATMENT OF ATTENTION DEFICIT DISORDERS AND ASSOCIATED SYMPTOMS
#291SOLVENT/POLYMER SOLUTIONS AS SUSPENSION VEHICLES
#292Oxycodone formulations
#293Controlled release dosage form
#294Controlled release dosage form with enhanced pharmacokinetics
#295STABLE NON-AQUEOUS SINGLE PHASE VISCOUS VEHICLES AND FORMULATIONS UTILIZING SUCH VEHICLES
#296METHODS OF MANUFACTURING VISCOUS LIQUID PHARMACEUTICAL FORMULATIONS
#297Electroosmotic pump and fluid pumping system including the same
#298INHALATION-TYPE PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF GOUT AND PREPARATION METHOD THEREOF
#299Methods for in vivo and in vitro use of graphene and other two-dimensional materials
#300SOLID DRUG TABLETS FOR IMPLANTABLE DRUG DELIVERY DEVICES